Bio-Techne Corp (TECH): Capital Expenditures
$28.85M
Year ended 2026-06-30
-9.0%
3-year compound annual growth
-8.2%
5-year compound annual growth
+5.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $28.85M | -7.0% | 2026-08-24, From 2025-07-01 |
| 2025-06-30 | $31.01M | -50.7% | 2026-08-24, From 2024-07-01 |
| 2024-06-30 | $62.88M | +64.4% | 2026-08-24, From 2023-07-01 |
| 2023-06-30 | $38.24M | -14.8% | 2025-08-22, From 2022-07-01 |
| 2022-06-30 | $44.91M | +1.4% | 2024-08-22, From 2021-07-01 |
| 2021-06-30 | $44.30M | -14.4% | 2023-08-23, From 2020-07-01 |
| 2020-06-30 | $51.74M | +103.6% | 2022-08-24, From 2019-07-01 |
| 2019-06-30 | $25.41M | +21.4% | 2021-08-25, From 2018-07-01 |
| 2018-06-30 | $20.93M | +37.9% | 2020-08-26, From 2017-07-01 |
| 2017-06-30 | $15.18M | -10.2% | 2019-11-06, From 2016-07-01 |
| 2016-06-30 | $16.90M | -15.1% | 2018-08-27, From 2015-07-01 |
| 2015-06-30 | $19.91M | +44.0% | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | $13.82M | -38.4% | 2016-08-29, From 2013-07-01 |
| 2013-06-30 | $22.45M | +273.2% | 2015-08-31, From 2012-07-01 |
| 2012-06-30 | $6.02M | +65.8% | 2014-08-29, From 2011-07-01 |
| 2011-06-30 | $3.63M | -21.8% | 2013-08-29, From 2010-07-01 |
| 2010-06-30 | $4.64M | -29.2% | 2012-08-29, From 2009-07-01 |
| 2009-06-30 | $6.56M | n/a | 2011-08-29, From 2008-07-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Bio-Techne Corp (TECH) | 2026-06-30 | $28.85M | -7.0% |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $6.97M | -34.8% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $2.47M | +119.6% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $192.00M | -81.7% |
| Repligen Corp (RGEN) | 2025-12-31 | $23.52M | -8.4% |
| Qiagen N.V. (QGEN) | 2025-12-31 | $201.05M | +20.3% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $8.43M | -70.4% |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $34.00M | -11.0% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $22.57M | +174.4% |
Compare TECH, HALO, BCRX, MRNA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗